Kreher Nerissa (CIK 0001741850)

Latest company ownership

TRDA - Entrada Therapeutics, Inc.
Role: Chief Medical Officer
Shares held
21,500
Last filed at
Sep 6, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2022Q3 2025Q4
RZLT - Rezolute, Inc.
Role: Director
Shares held
12,000
Last filed at
Nov 21, 2025
Confidence Score
51.6
2025Q4
Confidence Score History
2025Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jun 13, 2025 Jun 23, 2025 Rezolute, Inc. Director Buy 85.0 +3,076 8.92% ✗ $10K
Sep 1, 2023 Sep 6, 2023 Entrada Therapeutics, Inc. Chief Medical Officer Sell 91.3 +12,907 47.57% ✓ $17.8K
Aug 2, 2023 Aug 4, 2023 Entrada Therapeutics, Inc. Chief Medical Officer Sell 17.5 -26,710 -16.34% ✓ $394.2K
Mar 1, 2023 Mar 3, 2023 Entrada Therapeutics, Inc. Chief Medical Officer Sell 91.3 +25,814 166.37% ✓ $28.3K
Dec 30, 2022 Jan 3, 2023 Entrada Therapeutics, Inc. Chief Medical Officer Sell 10.0 -5,200 -25.10% ✓ $69.9K
Oct 25, 2022 Oct 27, 2022 Entrada Therapeutics, Inc. Chief Medical Officer Sell 22.5 -13,000 -10.48% ✓ $276.5K
Sep 26, 2022 Sep 28, 2022 Entrada Therapeutics, Inc. Chief Medical Officer Sell 28.8 -8,593 -9.36% ✓ $131.4K
Sep 21, 2022 Sep 23, 2022 Entrada Therapeutics, Inc. Chief Medical Officer Sell 28.8 -4,280 -9.36% ✓ $64.6K
Sep 15, 2022 Sep 19, 2022 Entrada Therapeutics, Inc. Chief Medical Officer Sell 52.5 -106 -0.51% ✓ $1.6K
Sep 8, 2022 Sep 12, 2022 Entrada Therapeutics, Inc. Chief Medical Officer Sell 41.3 -2,021 -4.65% ✓ $30.5K